Cargando…

Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis

Intestinal mucositis, a cytotoxic side effect of the antineoplastic drug 5-fluorouracil (5-FU), is characterized by ulceration, inflammation, diarrhea, and intense abdominal pain, making it an important issue for clinical medicine. Given the seriousness of the problem, therapeutic alternatives have...

Descripción completa

Detalles Bibliográficos
Autores principales: Batista, Viviane Lima, da Silva, Tales Fernando, de Jesus, Luís Cláudio Lima, Coelho-Rocha, Nina Dias, Barroso, Fernanda Alvarenga Lima, Tavares, Laisa Macedo, Azevedo, Vasco, Mancha-Agresti, Pamela, Drumond, Mariana Martins
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527409/
https://www.ncbi.nlm.nih.gov/pubmed/33042054
http://dx.doi.org/10.3389/fmicb.2020.544490
_version_ 1783589049377751040
author Batista, Viviane Lima
da Silva, Tales Fernando
de Jesus, Luís Cláudio Lima
Coelho-Rocha, Nina Dias
Barroso, Fernanda Alvarenga Lima
Tavares, Laisa Macedo
Azevedo, Vasco
Mancha-Agresti, Pamela
Drumond, Mariana Martins
author_facet Batista, Viviane Lima
da Silva, Tales Fernando
de Jesus, Luís Cláudio Lima
Coelho-Rocha, Nina Dias
Barroso, Fernanda Alvarenga Lima
Tavares, Laisa Macedo
Azevedo, Vasco
Mancha-Agresti, Pamela
Drumond, Mariana Martins
author_sort Batista, Viviane Lima
collection PubMed
description Intestinal mucositis, a cytotoxic side effect of the antineoplastic drug 5-fluorouracil (5-FU), is characterized by ulceration, inflammation, diarrhea, and intense abdominal pain, making it an important issue for clinical medicine. Given the seriousness of the problem, therapeutic alternatives have been sought as a means to ameliorate, prevent, and treat this condition. Among the alternatives available to address this side effect of treatment with 5-FU, the most promising has been the use of probiotics, prebiotics, synbiotics, and paraprobiotics. This review addresses the administration of these “biotics” as a therapeutic alternative for intestinal mucositis caused by 5-FU. It describes the effects and benefits related to their use as well as their potential for patient care.
format Online
Article
Text
id pubmed-7527409
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75274092020-10-09 Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis Batista, Viviane Lima da Silva, Tales Fernando de Jesus, Luís Cláudio Lima Coelho-Rocha, Nina Dias Barroso, Fernanda Alvarenga Lima Tavares, Laisa Macedo Azevedo, Vasco Mancha-Agresti, Pamela Drumond, Mariana Martins Front Microbiol Microbiology Intestinal mucositis, a cytotoxic side effect of the antineoplastic drug 5-fluorouracil (5-FU), is characterized by ulceration, inflammation, diarrhea, and intense abdominal pain, making it an important issue for clinical medicine. Given the seriousness of the problem, therapeutic alternatives have been sought as a means to ameliorate, prevent, and treat this condition. Among the alternatives available to address this side effect of treatment with 5-FU, the most promising has been the use of probiotics, prebiotics, synbiotics, and paraprobiotics. This review addresses the administration of these “biotics” as a therapeutic alternative for intestinal mucositis caused by 5-FU. It describes the effects and benefits related to their use as well as their potential for patient care. Frontiers Media S.A. 2020-09-17 /pmc/articles/PMC7527409/ /pubmed/33042054 http://dx.doi.org/10.3389/fmicb.2020.544490 Text en Copyright © 2020 Batista, da Silva, de Jesus, Coelho-Rocha, Barroso, Tavares, Azevedo, Mancha-Agresti and Drumond. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Batista, Viviane Lima
da Silva, Tales Fernando
de Jesus, Luís Cláudio Lima
Coelho-Rocha, Nina Dias
Barroso, Fernanda Alvarenga Lima
Tavares, Laisa Macedo
Azevedo, Vasco
Mancha-Agresti, Pamela
Drumond, Mariana Martins
Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis
title Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis
title_full Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis
title_fullStr Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis
title_full_unstemmed Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis
title_short Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis
title_sort probiotics, prebiotics, synbiotics, and paraprobiotics as a therapeutic alternative for intestinal mucositis
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527409/
https://www.ncbi.nlm.nih.gov/pubmed/33042054
http://dx.doi.org/10.3389/fmicb.2020.544490
work_keys_str_mv AT batistavivianelima probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis
AT dasilvatalesfernando probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis
AT dejesusluisclaudiolima probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis
AT coelhorochaninadias probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis
AT barrosofernandaalvarengalima probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis
AT tavareslaisamacedo probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis
AT azevedovasco probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis
AT manchaagrestipamela probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis
AT drumondmarianamartins probioticsprebioticssynbioticsandparaprobioticsasatherapeuticalternativeforintestinalmucositis